nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in intelligent DNA nanomachines for targeted cancer therapy
|
Chen, Bo |
|
|
26 |
4 |
p. 1018-1029 |
artikel |
2 |
Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 2: a discussion of chemical and biological data
|
Bender, Andreas |
|
|
26 |
4 |
p. 1040-1052 |
artikel |
3 |
‘Big Data’ informed drug development: a case for acceptability
|
Desai, Neel |
|
|
26 |
4 |
p. 865-869 |
artikel |
4 |
Biochemical pathways of copper complexes: progress over the past 5 years
|
Zehra, Siffeen |
|
|
26 |
4 |
p. 1086-1096 |
artikel |
5 |
Biomimetic bacterial and viral-based nanovesicles for drug delivery, theranostics, and vaccine applications
|
Loo, Yan Shan |
|
|
26 |
4 |
p. 902-915 |
artikel |
6 |
Building the future of drug discovery
|
Bloom, Bruce |
|
|
26 |
4 |
p. 863-864 |
artikel |
7 |
Contents page 1
|
|
|
|
26 |
4 |
p. i |
artikel |
8 |
Contents page 2
|
|
|
|
26 |
4 |
p. ii |
artikel |
9 |
Development of inhibitors for uPAR: blocking the interaction of uPAR with its partners
|
Yuan, Cai |
|
|
26 |
4 |
p. 1076-1085 |
artikel |
10 |
Drug discovery for enzymes
|
Rufer, Arne Christian |
|
|
26 |
4 |
p. 875-886 |
artikel |
11 |
Drugs acting on the renin–angiotensin system and SARS-CoV-2
|
Vitiello, Antonio |
|
|
26 |
4 |
p. 870-874 |
artikel |
12 |
Evaluating and evolving a screening library in academia: the St Jude approach
|
Nishiguchi, Gisele |
|
|
26 |
4 |
p. 1060-1069 |
artikel |
13 |
From ‘molecules of life’ to new therapeutic approaches, an evolution marked by the advent of artificial intelligence: the cases of chronic pain and neuropathic disorders
|
Kraus, Jean-Louis |
|
|
26 |
4 |
p. 1070-1075 |
artikel |
14 |
From venom to drugs: a review and critical analysis of Indian snake venom toxins envisaged as anticancer drug prototypes
|
Kalita, Bhargab |
|
|
26 |
4 |
p. 993-1005 |
artikel |
15 |
Human ClpP protease, a promising therapy target for diseases of mitochondrial dysfunction
|
Luo, Baozhu |
|
|
26 |
4 |
p. 968-981 |
artikel |
16 |
Inhibiting ferroptosis: A novel approach for stroke therapeutics
|
Jin, Yizhen |
|
|
26 |
4 |
p. 916-930 |
artikel |
17 |
Integration of AI and traditional medicine in drug discovery
|
Khan, Saifur R. |
|
|
26 |
4 |
p. 982-992 |
artikel |
18 |
New perspectives in oral peptide delivery
|
Zizzari, Alessandra T. |
|
|
26 |
4 |
p. 1097-1105 |
artikel |
19 |
Oral peptide delivery: challenges and the way ahead
|
Dubey, Sunil Kumar |
|
|
26 |
4 |
p. 931-950 |
artikel |
20 |
Specific and selective induction of miR-124 in immune cells by the quinoline ABX464: a transformative therapy for inflammatory diseases
|
Tazi, Jamal |
|
|
26 |
4 |
p. 1030-1039 |
artikel |
21 |
Superbranched polyglycerol nanostructures as drug delivery and theranostics tools for cancer treatment
|
Rahman, Mahfoozur |
|
|
26 |
4 |
p. 1006-1017 |
artikel |
22 |
The role of the multifunctional antimicrobial peptide melittin in gene delivery
|
Paray, Bilal Ahamad |
|
|
26 |
4 |
p. 1053-1059 |
artikel |
23 |
Tumor-infiltrating CD8+ T cell antitumor efficacy and exhaustion: molecular insights
|
Kumar, Sandeep |
|
|
26 |
4 |
p. 951-967 |
artikel |
24 |
Use of artificial intelligence to enhance phenotypic drug discovery
|
Malandraki-Miller, Sophia |
|
|
26 |
4 |
p. 887-901 |
artikel |